Series D - Elixir Pharmaceuticals - May 19, 2009 Funding Round Profile - Cointime

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Elixir Pharmaceuticals

company

Funding Round

Series D

Money Raised

$ 12M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
ARCH Venture Partners	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Nov 27, 2006	Debt Financing	$ 15M	Hercules Capital	Detail
Nov 27, 2006	Series C	$ 31M	Hercules Capital,ARCH Venture Partners	Detail
Oct 13, 2003	Series B	$ 40.50M	ARCH Venture Partners	Detail